Literature DB >> 8148444

Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome.

R H Keller1, J L Lane, N Klimas, W M Reiter, M A Fletcher, F van Riel, R Morgan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8148444     DOI： 10.1093/clinids/18.supplement_1.s154

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  A formal analysis of cytokine networks in chronic fatigue syndrome.

Authors:  Gordon Broderick; Jim Fuite; Andrea Kreitz; Suzanne D Vernon; Nancy Klimas; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2010-05-04       Impact factor: 7.217

2.  Association of chronic fatigue syndrome with human leucocyte antigen class II alleles.

Authors:  J Smith; E L Fritz; J R Kerr; A J Cleare; S Wessely; D L Mattey
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

Review 3.  Use of exercise for treatment of chronic fatigue syndrome.

Authors:  K K McCully; S A Sisto; B H Natelson
Journal:  Sports Med       Date:  1996-01       Impact factor: 11.136

4.  EBV Chronic Infections.

Authors:  Pizzigallo Eligio; Racciatti Delia; Gorgoretti Valeria
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-10       Impact factor: 2.576

5.  Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  K A Schlauch; S F Khaiboullina; K L De Meirleir; S Rawat; J Petereit; A A Rizvanov; N Blatt; T Mijatovic; D Kulick; A Palotás; V C Lombardi
Journal:  Transl Psychiatry       Date:  2016-02-09       Impact factor: 6.222

Review 6.  Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.

Authors:  Manuel Ruiz-Pablos; Bruno Paiva; Rosario Montero-Mateo; Nicolas Garcia; Aintzane Zabaleta
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

7.  Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.

Authors:  Ingrid G Rekeland; Alexander Fosså; Asgeir Lande; Irini Ktoridou-Valen; Kari Sørland; Mari Holsen; Karl J Tronstad; Kristin Risa; Kine Alme; Marte K Viken; Benedicte A Lie; Olav Dahl; Olav Mella; Øystein Fluge
Journal:  Front Med (Lausanne)       Date:  2020-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.